PT  - JOURNAL ARTICLE
AU  - Rachael Pung
AU  - Tze Minn Mak
AU  - CMMID COVID-19 working group
AU  - Adam J Kucharski
AU  - Vernon J. Lee
TI  - Serial intervals observed in SARS-CoV-2 B.1.617.2 variant cases
AID  - 10.1101/2021.06.04.21258205
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.04.21258205
4099  - http://medrxiv.org/content/early/2021/06/04/2021.06.04.21258205.short
4100  - http://medrxiv.org/content/early/2021/06/04/2021.06.04.21258205.full
AB  - Rapid growth of the SARS-CoV-2 variant B.1.617.2 has been observed in many countries. The factors driving the recent rapid growth of COVID-19 cases could be attributed to shorten generation intervals or higher transmissibility (effective reproduction number, R), or both. Establishing the reasons for the observed rapid growth is key for outbreak control. In this study, we analysed the serial interval of household transmission pairs infected with SARS-CoV-2 B.1.617.2 variant and compared with those who were infected prior to the occurrence of the major global SARS-CoV-2 variants. After controlling for confounding factors, our findings suggest no significant changes in the serial intervals for SARS-CoV-2 cases infected with the B.1.617.2 variant. This, in turn, lends support for the hypothesis of a higher R in B.1.617.2 cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe following funding sources are acknowledged as providing funding for the named authors. Singapore Ministry of Health (RP). This research was partly funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care (NIHR200908: AJK). Wellcome Trust (206250/Z/17/Z: AJK).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene and Tropical Medicine Ethics CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data to reproduce the analysis can be found at https://github.com/rachaelpung/serial_interval_covid_b.1.617.2 https://github.com/rachaelpung/serial_interval_covid_b.1.617.2